C12Y 401/01002
Oxalate decarboxylase
Official title: Oxalate decarboxylase (4.1.1.2)
C12Y401/01002 (Oxalate decarboxylase) appears on 29 US grants and 39 published applications in this corpus.
Search patents in C12Y- Granted patents
- 29
- Published applications
- 39
- Assignees
- 22
- Inventors
- 58
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 1 | 1 |
| 2013 | 3 | 2 |
| 2014 | 2 | 1 |
| 2015 | 2 | 4 |
| 2016 | 0 | 2 |
| 2017 | 4 | 0 |
| 2018 | 1 | 5 |
| 2019 | 3 | 1 |
| 2020 | 3 | 4 |
| 2021 | 3 | 2 |
| 2022 | 0 | 5 |
| 2023 | 2 | 2 |
| 2024 | 0 | 2 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods and compositions for treating hyperoxaluria23 Sep 2025US 12,421,518 B2Tenza, Inc.
- Recombinant oxalate decarboxylase expressed in filamentous fungi28 Mar 2023US 11,613,745 B2Wuhan Kangfude Biotechnology Co., Ltd.
- High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate14 Mar 2023US 11,603,524 B2Oxidien Pharmaceuticals, LLC
- Crystallized oxalate decarboxylase and methods of use28 Dec 2021US 11,208,700 B2Allena Pharmaceuticals, Inc.
- Glycosylated oxalate decarboxylase and preparation and application thereof10 Aug 2021US 11,085,033 B2Wuhan Kangfude Biotechnology Co., Ltd.
- Therapeutic Engineered Microbial Cell Systems and Methods for Treating Conditions in Which Oxalate is Detrimental1 Aug 2024US 2024/0254495 A1Unlocked Labs
- Bacteria engineered to treat disorders in which oxalate is detrimental20 Jun 2024US 2024/0197843 A1Synlogic Operating Company, Inc.
- Engineered oxalate decarboxylases7 Sep 2023US 2023/0279404 A1Codexis, Inc.
- Bacteria engineered to treat disorders in which oxalate is detrimental23 Mar 2023US 2023/0092431 A1Synlogic Operating Company, Inc.
- Crystallized oxalate decarboxylase and methods of use22 Dec 2022US 2022/0403361 A1Allena Pharmaceuticals, Inc.
Most cited
By later US patents
- Method for reducing oxalate53US 6,281,252 B1GelTex Pharmaceutical, Inc. · 2001
- Method for reducing oxalate40US 5,985,938 AGelTex Pharmaceuticals, Inc. · 1999
- Method for reducing oxalate40US 6,566,407 B2GelTex Pharmaceuticals, Inc. · 2003
- Method for reducing oxalate31US 6,177,478 B1GelTex Pharmaceuticals, Inc. · 2001
- Compositions and methods for treating or preventing oxalate-related disease19US 8,486,389 B2Oxthera, Inc. · 2013